C4 Therapeutics Inc (CCCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -59,032 | -31,620 | -83,892 | -68,234 | -43,551 |
| Depreciation Amortization | 2,176 | 1,145 | 4,090 | 2,741 | 1,673 |
| Accounts receivable | 4,007 | 3,944 | -1,232 | -361 | -1,729 |
| Accounts payable and accrued liabilities | -564 | -1,152 | -1,179 | -1,939 | -1,338 |
| Other Working Capital | -11,911 | -6,243 | -30,090 | -11,940 | -10,778 |
| Other Operating Activity | 16,533 | 7,330 | 25,338 | 18,439 | 12,787 |
| Operating Cash Flow | $-48,791 | $-26,596 | $-86,965 | $-61,294 | $-42,936 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -108,132 | -76,219 | -188,059 | -392,324 | -237,622 |
| PPE Investments | -701 | -172 | -1,277 | -1,168 | -1,168 |
| Sale Of Investment | 138,057 | 72,387 | N/A | 263,569 | 209,494 |
| Investing Cash Flow | $29,224 | $-4,004 | $-189,336 | $-129,923 | $-29,296 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 519 | 260 | 171,795 | 171,043 | 170,639 |
| Other Financing Activity | 220 | 220 | -395 | -109 | -289 |
| Financing Cash Flow | $739 | $480 | $171,400 | $170,934 | $170,350 |
| Beginning Cash Position | 79,403 | 79,403 | 184,304 | 184,304 | 184,304 |
| End Cash Position | 60,575 | 49,283 | 79,403 | 164,021 | 282,422 |
| Net Cash Flow | $-18,828 | $-30,120 | $-104,901 | $-20,283 | $98,118 |
| Free Cash Flow | |||||
| Operating Cash Flow | -48,791 | -26,596 | -86,965 | -61,294 | -42,936 |
| Capital Expenditure | -701 | -172 | -1,277 | -1,168 | -1,168 |
| Free Cash Flow | -49,492 | -26,768 | -88,242 | -62,462 | -44,104 |